This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Inhibrx Biosciences, Inc., Inhibrx, Inc.. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Jacob Gano: Innovator in CD33-Binding Polypeptides
Introduction
Jacob Gano is a notable inventor based in Encinitas, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that bind to CD33. With a total of 2 patents, Gano's work is paving the way for advancements in therapeutic applications.
Latest Patents
Gano's latest patents include innovative VHH-containing polypeptides that specifically bind to CD33. These polypeptides have potential uses in various medical applications, showcasing Gano's commitment to advancing healthcare solutions. The patents detail the structure and functionality of these polypeptides, emphasizing their significance in therapeutic contexts.
Career Highlights
Throughout his career, Jacob Gano has worked with prominent companies such as Inhibrx Biosciences, Inc. and Inhibrx, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his contributions to biotechnology.
Collaborations
Gano has collaborated with talented individuals such as William Crago and Angelica N Sanabria. These partnerships have fostered a creative environment that encourages innovation and the development of groundbreaking technologies.
Conclusion
Jacob Gano's work in the field of CD33-binding polypeptides exemplifies his dedication to innovation and advancement in biotechnology. His patents and collaborations highlight his significant impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile